Clinical Trial Recruiting
Only six percent of U.S. patients with a specific condition enroll in clinical trials,while the number of active clinical trials seeking patients has doubled over the last three years, reaching 29,000.
There is a significant bottleneck in time-to-market with steep costs for both patient outcomes and the pharmaceutical industry. BBN is evaluating efficient methods for matching patient interest and growth in clinical trials through analytical tools that can inform, educate, screen, and refer patients for the thousands of ongoing trials in the U.S.
